Ravi Agrawal Trust, a promoter group entity of Ajanta Pharma , sold 34,50,000 equity shares on June 9, 2026, reducing its stake in the pharmaceutical company. The transaction, executed via the open market, represented 2.76% of the company's paid-up equity share capital. Following the sale, the trust's holding has decreased to 10.24% of the total voting capital.

The disclosures were submitted to the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the company filed the necessary details under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirmed that the shares sold carried voting rights and that no other instruments such as warrants or convertible securities were involved in the transaction.

Shareholding Details

The table below outlines the changes in the shareholding pattern of Ravi Agrawal Trust following the disposal of shares:

The equity share capital of Ajanta Pharma remains unchanged at ₹ 24,98,71,248, comprising 12,49,35,624 shares of ₹ 2 each. Ravi Agrawal, acting as the trustee of Ravi Agrawal Trust, confirmed the sale in the disclosure addressed to BSE Limited and the National Stock Exchange of India Limited.

Aayush Agrawal, a promoter of Ajanta Pharma , has pledged 28,55,925 shares to secure a new loan, according to a regulatory filing submitted on June 4, 2026. The shares, representing 2.29% of the company's total share capital, were pledged in favor of CTL Trusteeship Limited. The disclosure was made in compliance with Regulation 31(1) and 31(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The filing details the shareholding and encumbrance status of various promoter entities. Aayush Agrawal, as trustee of the Aayush Agrawal Trust, holds a total of 1,41,12,924 shares, accounting for 11.30% of the company. Prior to this transaction, the entity held 85,89,162 encumbered shares. Following the pledge creation on June 2, 2026, the total encumbered holding for this entity stands at 1,14,45,087 shares.

Other promoter entities listed in the disclosure include Gabs Investments Pvt Ltd, which recently pledged 27,70,000 shares, and trusts associated with key individuals such as Yogesh M Agrawal, Rajesh M Agrawal, and Ravi P Agrawal. While some entities hold existing encumbered shares, the recent pledge activity is specific to Aayush Agrawal as trustee of the Aayush Agrawal Trust.

The following table summarizes the shareholding and encumbrance details disclosed by the promoters:

The document was signed by Aayush Agrawal, Trustee of the Aayush Agrawal Trust, and addressed to BSE Limited and the National Stock Exchange of India. The company secretary of Ajanta Pharma was also marked as a copyee.